Unknown

Dataset Information

Can peripheral blood be used as surrogate in detecting epidermal growth factor receptor mutation status in advanced non-small cell lung cancer patients? A meta-analysis.


ABSTRACT:

Background

Apply peripheral blood as a surrogate for detecting epidermal growth factor receptor mutation status in tumor, also called liquid biopsy, has been reported to be a feasible method in patients with advanced non-small lung cancer. But the diagnostic yield varies in different studies.

Methods

A meta-analysis was carried out to evaluate the sensitivity and specificity of peripheral blood in detection epidermal growth factor receptor mutation status in advanced non-small lung cancer patients. Publications up to October 2016 were searched using PubMed, Embase and Web of Science databases. Sensitivity, specificity and other parameters were pooled using the bivariate mixed-effects regression model.

Results

Fifteen studies meeting the inclusion criteria were include

SUBMITTER: Mao X 

PROVIDER: S-EPMC5652836 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature